Asymptomatic Small Pancreatic Endocrine Neoplasms.

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

August 31, 2024

Study Completion Date

December 31, 2024

Conditions
Non Functioning Pancreatic Endocrine Tumor
Interventions
DIAGNOSTIC_TEST

Radiological imaging studies

Patients will be submitted to radiological imaging studies (CT scan and/or MRI and/ or 68Gallium PET/CT and/or Octreoscan and/or EUS+FNAand/or Octreoscan and/or EUS+FNA) at diagnosis, and then every 6 months for the first two years and yearly thereafter for five years in the absence of significant changes on imaging or symptoms appearance. Every 12 months (or 6 months for patients with Ki67\> 2%) a high quality imaging (CT scan or MRI) is required.

OTHER

Quality of Life Assessment

quality of life and the perceived burden of surveillance or follow-up after surgery for participants, will be investigated by administrating HADS questionnaire and EORTC QLQ-C30 (version 3) and EORTC QLQ-GI.NET21 Module.

Trial Locations (1)

20132

RECRUITING

IRCCS San Raffaele Hospital, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER